 |
 |
 |
|
Quick Links
New Diabetes Materials Available for Health Care Instructors, Consumers
Be Active When You Have Diabetes, a new booklet and instructor's guide, helps people with diabetes learn about the health benefits of being physically active and ways to increase their activity level. The very easy-to-read booklet, written at a second- to third-grade reading level, contains tools to help consumers create and manage a physical activity plan, record target goals, and track their activities.
Be Active When You Have Diabetes: A Guide for Instructors is the companion instructor's guide developed for use in one-on-one or small group patient education. The flipbook provides color illustrations and simple teaching points on the corresponding instructor pages. The booklet and instructor's guide, from the National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK's) National Diabetes Information Clearinghouse (NDIC), include a list of resources from the NDIC, the National Diabetes Education Program, the NIDDK Weight-control Information Network, and the National Institute on Aging.
NIH Collaborates with India on Diabetes Research Effort
The National Institutes of Health (NIH) is partnering with the Indian Council of Medical Research to collaborate on diabetes research and ways to improve prevention and treatment. The U.S. Department of Health and Human Services signed a joint statement with India's Health and Family Welfare Minister to begin a formal research relationship.
"Both the United States and India have a vested interest in improving our understanding of and treatment for diabetes, and in finding economical ways to do both," said NIDDK Director Griffin P. Rodgers, M.D., M.A.C.P. "Initiating this research relationship will enable both countries to share expertise and engage each other in research to lessen the burden of diabetes—in the U.S., India, and around the world." The NIDDK will lead the U.S. role in the collaboration.
In February 2013, the NIDDK and the Indian Council of Medical Research held a scientific workshop to identify opportunities for collaboration between the two countries in high-priority diabetes research areas of joint interest. A summary of the workshop can be found in the recent NIDDK Director's Update.
NIDDK Seeks Director for the Type 2 Diabetes Prevention Program
The NIDDK is looking for a talented and experienced program officer (medical officer) to serve in the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) as director of the Type 2 Diabetes Prevention Program and as a senior scientific advisor to the NIDDK for human subject research in type 2 diabetes. The incumbent would be responsible for the scientific and administrative management of a portfolio that may include multicenter and single-site clinical studies, and for the development of joint research activities with other government organizations.
An appropriate applicant must possess an M.D. or equivalent degree, and expertise in endocrinology, internal medicine, or another specialty relevant to diabetes. Strong candidates should have conducted independent research, and be able to demonstrate the knowledge and insight needed to identify important scientific opportunities in diabetes research and to participate in the design of clinical trials or observational studies. Experience in translational research is also desirable.
The NIDDK Medical Officer vacancy announcement for this position will be posted April 5–16, 2013, at www.jobs.nih.gov/. Search for announcement number NIH-NIDDK-DH-15-855001 in the "Search for NIH Jobs" box.
For questions or information about this and upcoming position openings in DEM for talented medical officers (M.D.) to manage clinical studies and program directors (M.D. or Ph.D.) to help move basic research discoveries toward disease prevention and treatment, please contact DEM Director Dr. Judith Fradkin at fradkinj@mail.nih.gov.
Find other exciting new job opportunities at the NIDDK! Check back often to view vacancies, updated regularly, as positions are advertised for 5–10 days. For more information, go to: www2.niddk.nih.gov/AboutNIDDK/NIDDKJobOpportunities/.
NIDDK, NIH, and DHHS are equal opportunity employers.
New and Updated Publications
- Be Active When You Have Diabetes
- Be Active When You Have Diabetes: A Guide for Instructors
- Comparing Tests for Diabetes and Prediabetes: A Quick Reference Guide
- Prevent diabetes problems: Keep your mouth healthy (Spanish)
- Sickle Cell Trait and Other Hemoglobinopathies and Diabetes: Important Information for Providers
Previous Issues of Diabetes Research and News
October 2012
DPP Finds Lifestyle Change, Metformin are Cost-EffectiveOutcomes and Cost Analysis Published in Diabetes Care
Programs to prevent or delay type 2 diabetes in high-risk adults would result in fewer people developing diabetes and lower health care costs over time, researchers conclude in a new study funded by the National Institutes of Health. The programs were tested in the landmark Diabetes Prevention Program (DPP) clinical trial over 10 years. "We don’t often see new therapies that are more effective and at the same time less costly than usual care, as was the case with metformin in the DPP," said Griffin P. Rodgers, M.D., M.A.C.P., director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). |
Fraud Alert for People with DiabetesPeople with diabetes are becoming targets in a scheme to steal their money and personal information. Criminals are calling people with diabetes to request financial data or Medicare account information with the promise of "free" diabetes supplies, like test strips, glucose meters, or lancets, among others. As part of the scam, the callers pretend to represent the Government, well-known diabetes organizations, or Medicare. Health and Human Services urges people not to share their information and to report the call to the Office of Inspector General 1-800-HHS-TIPS. |
Weight Loss and Fitness Reduce the Risk of Lost Mobility
Weight loss and increased physical fitness nearly halved the risk of losing mobility in overweight or obese adults with type 2 diabetes, according to 4-year results from the Look AHEAD (Action for Health in Diabetes) trial funded by the National Institutes of Health. "This study of mobility highlights the value of finding ways to help adults with type 2 diabetes keep moving as they age. We know that when adults lose mobility, it becomes difficult for them to live on their own, and they are likely to develop more serious health problems, increasing their health care costs," said Mary Evans, Ph.D., project scientist for the study. |
New and Updated Publications |
April 2012
Diagnosing Diabetes with the A1C TestNew NIDDK A1C Test Fact Sheet Now Available
Check out The A1C Test and Diabetes, a new fact sheet from the National Diabetes Information Clearinghouse of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The A1C test is a convenient test that offers important information about an individual’s long-term blood glucose control. The fact sheet addresses how to interpret results of the A1C test and also describes the accuracy of the test. The publication provides information that is particularly relevant in light of new recommendations to use the A1C test to diagnose type 2 diabetes and prediabetes. Blood tests, such as the A1C test, are especially important because at first, a person may have no symptoms of diabetes or prediabetes. Therefore, early diagnosis and treatment are important in preventing type 2 diabetes and its complications. |
Research May Lead to Diabetes Drugs with Fewer Side EffectsIn an effort to cultivate a new generation of diabetes drugs with fewer side effects, NIDDK-funded scientists developed compounds that successfully reduced glucose levels and increased insulin sensitivity in mice. The research was based in part on the effective mechanisms at work in thiazolidinediones such as Avandia and Actos, which have helped patients achieve lower blood glucose levels, but which in recent years have also come to be known for dangerous side effects such as fluid retention, bone loss, weight gain, bladder cancer, and congestive heart failure. |
New Publications |
Page last updated April 3, 2013
